| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
752,280,000 |
| Market
Cap: |
12.34(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$16.43 - $39.67 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1016 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Terumo is mainly engaged in the manufacture and sale of medical products and equipment in Japan and overseas. Along with its subsidiaries and associated companies, Co. operates in three business segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. Co. offers angiographic guidewires, introducer sheaths, coils, stents and intrasaccular devices, oxygenators, cardio-pulmonary bypass systems, artificial vascular grafts, syringes, infusion pumps, pain management products, nutritious food, blood glucose monitoring systems, disposal needles for pen-infectors, insulin patch pumps, blood bags, component collection systems, and others.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gigliotti Robert S |
Director |
– • – |
2003-07-15 |
4 |
A |
$0.03 |
$1,075 |
D/D |
43,000 |
656,000 |
|
- |
|
| Baker Harvey |
officerTitle |
• – – |
2003-07-08 |
4 |
B |
$2.30 |
$900 |
D/D |
392 |
3,157 |
2.74 |
- |
|
| Harington Allen |
Director |
– • • |
2001-06-20 |
5 |
A |
$0.00 |
$10,000 |
I/I |
10,000,000 |
10,000,000 |
|
- |
|
| Baratta Robert O Md |
Chief Executive Officer |
• • – |
2000-08-16 |
4 |
B |
$12.50 |
$2,500 |
D/D |
200 |
200 |
2.81 |
- |
|
| Lampropoulos Fred P |
Chairman, President, CEO |
• • • |
1988-08-08 |
4 |
A |
$20.00 |
$593,120 |
I/I |
29,656 |
29,656 |
|
- |
|
| Stanger Kent W |
Chief Financial Officer |
• • – |
1988-08-08 |
4 |
A |
$4.77 |
$521,560 |
I/I |
109,351 |
26,078 |
|
- |
|
181 Records found
|
|
Page 8 of 8 |
|
|
0.01 (0.06%) 
